niceritrol has been researched along with Hyperlipoproteinemias in 4 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
Hyperlipoproteinemias: Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prophylactic treatment of the hyperlipoproteinemia with the drugs niceritrol (Perycit) and beta-pyridylcarbinol (Ronicol) significantly reduced the elevated plasma cholesterol level and reduced the degree of atherosclerosis in the abdominal aorta and the coronary arteries." | 1.27 | [Experimental hyperlipoproteinemia and arteriosclerosis in minipigs--effect of various drugs]. ( Jacobsson, L, 1986) |
| "Niceritrol treatment was associated with increased blood glucose, decreased K value, elevated fasting serum insulin and serum insulin at 60 min during IVGTT." | 1.26 | Changes in glucose tolerance and plasma insulin during lipid-lowering treatment with diet, clofibrate and niceritrol. ( Hellsing, K; Lithell, H; Vessby, B, 1982) |
| "Niceritrol treatment significantly reduced the Chol/TG ratio in VLDL while no such effect was seen during clofibrate administration." | 1.26 | Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease. ( Borberg, J; Gustafsson, IB; Lithell, H; Vessby, B, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lithell, H | 2 |
| Vessby, B | 2 |
| Hellsing, K | 1 |
| Murase, T | 1 |
| Gustafsson, IB | 1 |
| Borberg, J | 1 |
| Jacobsson, L | 1 |
1 review available for niceritrol and Hyperlipoproteinemias
| Article | Year |
|---|---|
[High Lp (a) concentrations].
Topics: Arteriosclerosis; Blood Component Removal; Coronary Artery Disease; Humans; Hyperlipoproteinemias; H | 1998 |
3 other studies available for niceritrol and Hyperlipoproteinemias
| Article | Year |
|---|---|
Changes in glucose tolerance and plasma insulin during lipid-lowering treatment with diet, clofibrate and niceritrol.
Topics: Aged; Arteriosclerosis; Blood Glucose; Body Weight; Clofibrate; Dietary Carbohydrates; Female; Gluco | 1982 |
Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
Topics: Adult; Aged; Arteriosclerosis; Clofibrate; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipopr | 1979 |
[Experimental hyperlipoproteinemia and arteriosclerosis in minipigs--effect of various drugs].
Topics: Animals; Arteries; Arteriosclerosis; Cholesterol; Hypercholesterolemia; Hyperlipoproteinemias; Hypol | 1986 |